Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 15, 2026

Inducible T7 RNA Polymerase-mediated Multigene Expression System, pMGX
10:09

Inducible T7 RNA Polymerase-mediated Multigene Expression System, pMGX

Published on: June 27, 2017

Engineering human PON1 in an E. coli expression system.

Stephanie M Suzuki1, Richard C Stevens, Rebecca J Richter

  • 1Departments of Medicine (Div. of Medical Genetics) and Genome Sciences, University of Washington, Seattle, Washington, USA. stephis@u.washington.edu

Advances in Experimental Medicine and Biology
|March 12, 2010
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Complaints Involving Sonographers: What Three Decades of Cases From A Public New Zealand Database Can Teach Us.

Journal of medical radiation sciences·2026
Same author

Unmet Need and Treatment Expectations of Previously Treated Patients With Epidermal Growth Factor Receptor-Mutated Advanced Nonsmall Cell Lung Cancer: A Qualitative Interview Study.

Clinical lung cancer·2026
Same author

Real-World Clinical Outcomes and Treatment Patterns in Advanced/Metastatic EGFR-Mutant NSCLC After Progression on First-Line Osimertinib for French Patients.

Advances in therapy·2026
Same author

Single-cell RNA sequencing of human embryonic stem cells reveals immediate and deferred transcriptomic responses to retinoic acid-mediated effects across cell subpopulations.

Toxicology in vitro : an international journal published in association with BIBRA·2026
Same author

Sex Differences in Enrolment, Adherence, and Satisfaction in Canadian Stroke Telerehabilitation Studies.

Archives of physical medicine and rehabilitation·2025
Same author

Facilitators and Barriers to Participation in Exercise-Based Telerehabilitation in Individuals with Stroke: A Scoping Review of Quantitative and Qualitative Studies.

Telemedicine journal and e-health : the official journal of the American Telemedicine Association·2025
Same journal

Mammalian Respiratory Chain Complex Assemblies and Their Links to Mitochondria Stress-Induced Human Diseases.

Advances in experimental medicine and biology·2026
Same journal

Enzyme Assemblies in Nucleotide Metabolism: Structure, Regulation, and Disease Implications.

Advances in experimental medicine and biology·2026
Same journal

The Pyruvate Dehydrogenase Complex: A 90-Year-Old Enigma Shaping the Future of Structural Enzymology.

Advances in experimental medicine and biology·2026
Same journal

Regulation of the Anti-termination RNA Transcription Complex by Lon-Mediated Lambda N Degradation.

Advances in experimental medicine and biology·2026
Same journal

PCNA Macromolecular Complexes: PCNA Serves as a Molecular Hub Regulating Multiple Cellular Processes Inside and Outside of the Nucleus.

Advances in experimental medicine and biology·2026
Same journal

Dynamic Assemblies in Genome Maintenance.

Advances in experimental medicine and biology·2026
See all related articles

We developed a method to produce pure, active recombinant human paraoxonase-1 (rHuPON1) in E. coli. This bacterially-derived rHuPON1 protects mice from organophosphorus compounds and can be used therapeutically.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Toxicology

Background:

  • Producing recombinant human paraoxonase-1 (rHuPON1) in bacterial systems has been challenging.
  • Previous methods often involved complex eukaryotic systems or engineered hybrid molecules.

Purpose of the Study:

  • To establish a reliable method for producing pure, native rHuPON1 using an E. coli expression system.
  • To evaluate the stability, activity, and therapeutic potential of bacterially-expressed rHuPON1.

Main Methods:

  • Review of methods and protocols for rHuPON1 production in E. coli.
  • Purification using conventional column chromatography.
  • Testing rHuPON1 efficacy in PON1 knockout mice exposed to diazoxon.

Main Results:

More Related Videos

The Multifaceted Benefits of Protein Co-expression in Escherichia coli
12:48

The Multifaceted Benefits of Protein Co-expression in Escherichia coli

Published on: February 5, 2015

Overexpression and Purification of Human Cis-prenyltransferase in Escherichia coli
07:35

Overexpression and Purification of Human Cis-prenyltransferase in Escherichia coli

Published on: August 3, 2017

Related Experiment Videos

Last Updated: Jun 15, 2026

Inducible T7 RNA Polymerase-mediated Multigene Expression System, pMGX
10:09

Inducible T7 RNA Polymerase-mediated Multigene Expression System, pMGX

Published on: June 27, 2017

The Multifaceted Benefits of Protein Co-expression in Escherichia coli
12:48

The Multifaceted Benefits of Protein Co-expression in Escherichia coli

Published on: February 5, 2015

Overexpression and Purification of Human Cis-prenyltransferase in Escherichia coli
07:35

Overexpression and Purification of Human Cis-prenyltransferase in Escherichia coli

Published on: August 3, 2017

  • Successfully produced stable and active rHuPON1 in E. coli.
  • Bacterially-derived rHuPON1 demonstrated protective effects against organophosphorus compound exposure in vivo.
  • The produced rHuPON1 lacks glycosylation, reducing potential immunogenic complications.

Conclusions:

  • Bacterial expression offers a scalable and efficient method for producing functional rHuPON1.
  • rHuPON1 has therapeutic potential for treating organophosphorus poisoning and managing diseases linked to low PON1 status.
  • Bacterial systems facilitate easy mutagenesis for developing enhanced rHuPON1 variants.